Comparison between quantitative nucleic acid sequence-based amplification, real-time reverse transcriptase PCR, and real-time PCR for quantification of Leishmania parasites.
about
Nucleic acid sequence-based amplification with oligochromatography for detection of Trypanosoma brucei in clinical samplesRapid molecular assays for specific detection and quantitation of Loa loa microfilaremiaDynamics of parasite clearance in cutaneous leishmaniasis patients treated with miltefosineA poor-quality generic drug for the treatment of visceral leishmaniasis: a case report and appealSafety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trialGrowth factor and Th2 cytokine signaling pathways converge at STAT6 to promote arginase expression in progressive experimental visceral leishmaniasisMonitoring the response of patients with cutaneous leishmaniasis to treatment with pentamidine isethionate by quantitative real-time PCR, and identification of Leishmania parasites not responding to therapy.Studies on the sand fly fauna (Diptera: Psychodidae) in high-transmission areas of cutaneous leishmaniasis in the Republic of Suriname.Is the dog a possible reservoir for cutaneous leishmaniasis in suriname?Development of a reverse transcriptase loop-mediated isothermal amplification (LAMP) assay for the sensitive detection of Leishmania parasites in clinical samplesPhase II evaluation of sensitivity and specificity of PCR and NASBA followed by oligochromatography for diagnosis of human African trypanosomiasis in clinical samples from D.R. Congo and Uganda.Viability and burden of Leishmania in extralesional sites during human dermal leishmaniasis.Application of an improved enzyme-linked immunosorbent assay method for serological diagnosis of canine leishmaniasis.Mucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon.Importance of nonenteric protozoan infections in immunocompromised people.Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial.American tegumentary leishmaniasis and HIV-AIDS association in a tertiary care center in the Brazilian AmazonAnimal models for the analysis of immune responses to leishmaniasis.Serial quantitative PCR assay for detection, species discrimination, and quantification of Leishmania spp. in human samplesSensitive diagnosis of cutaneous leishmaniasis by lesion swab sampling coupled to qPCR.Quantification of Leishmania infantum kinetoplast DNA for monitoring the response to meglumine antimoniate therapy in visceral leishmaniasis.Potentials and limitations of molecular diagnostic methods in food safety.Comparison of molecular quantification of Plasmodium falciparum gametocytes by Pfs25 qRT-PCR and QT-NASBA in relation to mosquito infectivity.Diagnosis of visceral leishmaniasis: developments over the last decade.Rapid identification of Leishmania spp. in formalin-fixed, paraffin-embedded tissue samples by fluorescence in situ hybridization.Efficacy of Paromomycin-Chloroquine Combination Therapy in Experimental Cutaneous Leishmaniasis.Accordance and concordance of PCR and NASBA followed by oligochromatography for the molecular diagnosis of Trypanosoma brucei and Leishmania.A versatile qPCR assay to quantify trypanosomatidic infections of host cells and tissues.Duplex quantitative Reverse-Transcriptase PCR for simultaneous assessment of drug activity against Leishmania intracellular amastigotes and their host cellsSensitive Molecular Diagnostics for Cutaneous Leishmaniasis.Molecular detection of infection homogeneity and impact of miltefosine treatment in a Syrian golden hamster model of Leishmania donovani and L. infantum visceral leishmaniasis.Leishmaniases diagnosis: an update on the use of immunological and molecular tools.Low-cost liquid medium for in vitro cultivation of Leishmania parasites in low-income countries.Detection of parasite antigens in Leishmania infantum-infected spleen tissue by monoclonal antibody-, piezoelectric-based immunosensors.Real-time PCR to quantify Leishmania donovani in hamsters.The emergence of Leishmania major and Leishmania donovani in southern Turkey.Magnetic Bead/Gold Nanoparticle Double-Labeled Primers for Electrochemical Detection of Isothermal Amplified Leishmania DNA.Topical Treatment for Cutaneous Leishmaniasis: Dermato-Pharmacokinetic Lead Optimization of Benzoxaboroles.Leishmania sp. identification by PCR associated with sequencing of target SSU rDNA in paraffin-embedded skin samples stored for more than 30 years.Real-time PCR applications for diagnosis of leishmaniasis.
P2860
Q24645104-EBA618F9-004C-4433-B197-460D64A85364Q28476749-34BD03CB-3EA5-4846-B62B-5A186911DEECQ28478376-71DCC0CA-F42D-472C-AF44-4176A1071953Q28483975-7FEEA7E9-C0BA-4A1E-A5D7-6A943B6F1D1EQ28538775-59D6D85D-7739-4D99-9E7C-3001165C65F7Q28540097-39290D0F-367E-4747-ACB8-3CB1A12FD244Q29353558-FD9C5C99-46C3-4382-86DD-3433C9CD25A9Q29353718-CAD0CA73-3149-438F-A97E-FC8AA08945BBQ29353730-CDFC2361-D2A8-4D0B-997E-9632CE94D1A0Q29353857-7740DE8E-271E-4EA4-90B6-8868A74328DFQ33631307-0FF8DAC9-482D-4DD9-BD9D-887F63C34B1FQ33697819-69D1624F-6854-42EE-A641-83C7B1F595BAQ33827287-15AF18C8-414D-4ABB-834F-73D07C3D7F7BQ33847397-1675181A-A828-416A-B9C2-01AC85CB25D0Q34189873-A8B8B879-23B5-44C2-92E0-58EB25E772FDQ35163598-443BE7AC-9217-4E02-BF48-9B5C55F26030Q35186855-1AA4BD9D-F90C-461B-821F-F77ECC726FBCQ35188674-5FD867E7-8B84-4850-85DF-7184FE7F7984Q35530589-CA2C137E-C5C8-461D-A2DC-D8EF50801D59Q36302978-707DF051-AF54-4CC6-AA77-2DA03C804B63Q37119386-62EA5013-A287-47A8-8E4E-17BC2871964AQ37344709-35BC93B7-6DDB-4D22-84F2-5738A78A98D6Q37400894-A4C7E56B-2A99-493D-A1C7-F0F41642F656Q37953841-0CF12E7E-703C-4123-BC5B-50B05B187A31Q38323721-8C89F913-4A7A-416D-AEBE-61503A1C14E0Q38729021-9FE34205-2C17-4A0D-A11A-8E33BCD6259AQ38872485-8181DB72-FEEF-4EF0-BECA-5C5D403CFA7DQ38908864-507BD476-8D1C-4B65-BCC0-B6158BE86706Q39548200-E49F69F2-6F40-4EBA-B19D-4A7ECE4898FBQ40088392-E19F32ED-EC71-410E-A938-CCF40654268BQ40614369-2EB23EE8-446D-4F69-93D5-B68B48E1C79AQ41147080-2B80CEA6-E2DF-4F07-B747-CB2CD94E8DA5Q41900706-414B2210-754E-4B7B-87EA-2807D804BD70Q43584736-65FDB3B1-5E78-49DF-86A3-6C2025D6E0F8Q44261093-B5673216-0D83-4412-B855-AEAF9BF8F893Q46943400-233FF218-AC45-4AC4-91B7-BFF262BAFDE5Q51640832-24F1F6C4-40C6-4558-8AB5-39C357628D0FQ53080458-7C6E0AF3-9163-42CE-8B28-54CB655525E4Q54397151-BE75DA0A-4D8F-4C55-8AFF-284ABCF172CBQ55311477-38F148E4-CD2C-4B7D-B442-664F7408B980
P2860
Comparison between quantitative nucleic acid sequence-based amplification, real-time reverse transcriptase PCR, and real-time PCR for quantification of Leishmania parasites.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Comparison between quantitativ ...... ation of Leishmania parasites.
@ast
Comparison between quantitativ ...... ation of Leishmania parasites.
@en
type
label
Comparison between quantitativ ...... ation of Leishmania parasites.
@ast
Comparison between quantitativ ...... ation of Leishmania parasites.
@en
prefLabel
Comparison between quantitativ ...... ation of Leishmania parasites.
@ast
Comparison between quantitativ ...... ation of Leishmania parasites.
@en
P2093
P2860
P356
P1476
Comparison between quantitativ ...... ation of Leishmania parasites.
@en
P2093
Gerard Schoone
Henk Schallig
Inge Peekel
Jorge Guerra
Leíla Coelho
Wendy van der Meide
William Faber
P2860
P356
10.1128/JCM.01416-07
P407
P577
2007-10-24T00:00:00Z